PMID- 25931003
OWN - NLM
STAT- MEDLINE
DCOM- 20160526
LR  - 20150825
IS  - 1468-3083 (Electronic)
IS  - 0926-9959 (Linking)
VI  - 29
IP  - 9
DP  - 2015 Sep
TI  - Guidelines of care for vascular lasers and intense pulse light sources from the 
      European Society for Laser Dermatology.
PG  - 1661-78
LID - 10.1111/jdv.13177 [doi]
AB  - AIM: Lasers and non-coherent intense pulse light sources (IPLS) are based on the 
      principle of selective photothermolysis and can be used for the treatment of many 
      vascular skin lesions. A variety of lasers has been developed for the treatment 
      of congenital and acquired vascular lesions which incorporate these concepts into 
      their design. Although laser and light sources are very popular due to their 
      non-invasive nature, caution should be considered by practitioners and patients 
      to avoid permanent side-effects. The aim of these guidelines is to give 
      evidence-based recommendations for the use of lasers and IPLS in the treatment of 
      vascular lesions. METHODS: These guidelines were produced by a Consensus Panel 
      made up of experts in the field of vascular laser surgery under the auspices of 
      the European Society of Laser Dermatology. Recommendations on the use of vascular 
      lasers and IPLS were made based on the quality of evidence for efficacy, safety, 
      tolerability, cosmetic outcome, patient satisfaction/preference and, where 
      appropriate, on the experts' opinion. The recommendations of these guidelines are 
      graded according to the American College of Chest Physicians Task Force 
      recommendations on Grading Strength of Recommendations and Quality of Evidence in 
      Clinical Guidelines. RESULTS: Lasers and IPLS are very useful and sometimes the 
      only available method to treat various vascular lesions. It is of a paramount 
      importance that the type of laser or IPLS and their specific parameters are 
      adapted to the indication but also that the treating physician is familiar with 
      the device to be used. The crucial issue in treating vascular lesions is to 
      recognize the immediate end-point after laser treatment. This is the single most 
      important factor to ensure both the efficacy of the treatment and avoidance of 
      serious side-effects.
CI  - (c) 2015 European Academy of Dermatology and Venereology.
FAU - Adamic, M
AU  - Adamic M
AD  - Dermatology Center Parmova, Ljubljana, Slovenia.
FAU - Pavlovic, M D
AU  - Pavlovic MD
AD  - Dermatology Center Parmova, Ljubljana, Slovenia.
AD  - Faculty of Medicine, University of Maribor, Maribor, Slovenia.
FAU - Troilius Rubin, A
AU  - Troilius Rubin A
AD  - Department of Dermatology, Centre for Laser and Vascular Anomalies, Skane 
      University Hospital, Malmo, Sweden.
FAU - Palmetun-Ekback, M
AU  - Palmetun-Ekback M
AD  - Department of Dermatology, University Hospital Orebro, Orebro, Sweden.
FAU - Boixeda, P
AU  - Boixeda P
AD  - Laser Service, Department of Dermatology, Ramon y Cajal Hospital, University of 
      Alcala, Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
DEP - 20150430
PL  - England
TA  - J Eur Acad Dermatol Venereol
JT  - Journal of the European Academy of Dermatology and Venereology : JEADV
JID - 9216037
SB  - IM
MH  - Dermatologic Surgical Procedures/*instrumentation/standards
MH  - Dermatology/*standards
MH  - Europe
MH  - Humans
MH  - Laser Therapy/*standards
MH  - Lasers/*standards
MH  - *Societies, Medical
EDAT- 2015/05/02 06:00
MHDA- 2016/05/27 06:00
CRDT- 2015/05/02 06:00
PHST- 2014/11/14 00:00 [received]
PHST- 2015/04/07 00:00 [accepted]
PHST- 2015/05/02 06:00 [entrez]
PHST- 2015/05/02 06:00 [pubmed]
PHST- 2016/05/27 06:00 [medline]
AID - 10.1111/jdv.13177 [doi]
PST - ppublish
SO  - J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1661-78. doi: 10.1111/jdv.13177. 
      Epub 2015 Apr 30.